EVENTS10
ARTICLES5
CATEGORYMedical
Active
Phase II/III clinical trial readouts from publicly traded biotech companies. Primary endpoints, safety signals, and regulatory pathway updates.
LATEST EVENTS
| Entity | Type | Summary | Impact | Confidence |
|---|---|---|---|---|
| Cipla USA Inc. | regulatory | Cipla USA received FDA approval for its generic Nintedanib Capsules, a therapeutic equivalent to Boehringer Ingelheim's … | medium | 95% |
| Eli Lilly | regulatory | FDA approved Eli Lilly's Foundayo (orforglipron) for chronic weight management, marking the fastest NME approval since 2… | high | 95% |
| Novo Nordisk | regulatory | FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for type 2 diabetes, supported by Phase 3 data. | high | 95% |
| GSK | regulatory | GSK's Exdensur was approved in China for severe asthma following successful Phase 3 trials. | high | 99% |
| Agios Pharmaceuticals | regulatory | Agios Pharmaceuticals is pursuing accelerated FDA approval for Pyrukynd in sickle cell disease. | medium | 95% |
| Novo Nordisk | regulatory | Novo Nordisk's once-weekly Awiqli received FDA approval for Type 2 diabetes based on Phase 3a clinical data. | high | 99% |
| Viatris | regulatory | Viatris' Ryzumvi eye drop application for presbyopia was accepted by the FDA, with a PDUFA date in October 2026. | medium | 98% |
| Viridian Therapeutics | regulatory | Viridian Therapeutics' candidate veligrotug has a PDUFA target action date of June 30, 2026. | medium | 95% |
| Viridian Therapeutics | regulatory | Viridian Therapeutics anticipates submitting a Biologics License Application (BLA) for elegrobart in Q1 2027. | medium | 95% |
| Viridian Therapeutics | product | Viridian Therapeutics announced positive topline results from its Phase 3 REVEAL-1 clinical trial for elegrobart in acti… | high | 98% |
WATCHER CONFIG
query: biotech clinical trial results phase III primary endpoint FDA approval PDUFA safety data
event_types: ['product', 'regulatory', 'financial']
impact_floor: medium
time_window: 7
Signal event details
Biotech Clinical Trial Results
FIELD DATA
RAW DATA